Immune response to Fc tagged GP5 glycoproteins of porcine reproductive and respiratory syndrome virus

Viral Immunology

Volumn 27, Issue 7, 2014, Pages 343-349

  Wu, Fang ^a   Peng, Kefeng ^a   Tian, Jiao ^a   Xu, Xiaodong ^a   Zhou, Enmin ^a   Chen, Hongying ^a  

^a NORTHWEST A F UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 5; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; GLYCOPROTEIN 5, PRRSV; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTERIVIRUS; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; INSECT CELL; MOUSE; NONHUMAN; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PROTEIN EXPRESSION; PROTEIN PURIFICATION; VACCINATION; VIRUS ENVELOPE; VIRUS NEUTRALIZATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BLOOD; GERMFREE ANIMAL; IMMUNOLOGY; METABOLISM; PIG; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS; SERODIAGNOSIS; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; FEMALE; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SPECIFIC PATHOGEN-FREE ORGANISMS; SWINE; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 84907028901     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2014.0041     Document Type: Article

References (39)

1. Ansari IH, Kwon B, Osorio FA, and Pattnaik AK. Influence of N-linked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodies. J Virol 2006;80:3994-4004.
2. Bastos RG, Dellagostin OA, Barletta RG, Doster AR, Nelson E, Zuckermann F, and Osorio FA. Immune response of pigs inoculated with Mycobacterium bovis BCG expressing a truncated form of GP5 and M protein of porcine reproductive and respiratory syndrome virus. Vaccine 2004; 22:467-474.
3. Chen H, Xu X, and Jones IM. Immunogenicity of the outer domain of a HIV-1 clade C gp120. Retrovirology 2007; 4:33.
4. Chia MY, Hsiao SH, Chan HT, et al. The immunogenicity of DNA constructs co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus conjugated by GPGP linker in pigs. Vet Microbiol 2010;146: 189-199.
5. Ellingson JS, Wang Y, Layton S, Ciacci-Zanella J, Roof MB, and Faaberg KS. Vaccine efficacy of porcine reproductive and respiratory syndrome virus chimeras. Vaccine 2010;28:2679-2686.
6. Faaberg KS, Hocker JD, Erdman MM, et al. Neutralizing antibody responses of pigs infected with natural GP5 N-glycan mutants of porcine reproductive and respiratory syndrome virus. Viral Immunol 2006;19:294-304.
7. Fang L, Jiang Y, Xiao S, Niu C, Zhang H, and Chen H. Enhanced immunogenicity of the modified GP5 of porcine reproductive and respiratory syndrome virus. Virus Genes 2006;32:5-11.
8. Firth AE, Zevenhoven-Dobbe JC, Wills NM, et al. Discovery of a small arterivirus gene that overlaps the GP5 coding sequence and is important for virus production. J Gen Virol 2011;92:1097-1106.
9. Gonin P, Pirzadeh B, Gagnon CA, and Dea S. Seroneutralization of porcine reproductive and respiratory syndrome virus correlates with antibody response to the GP5 major envelope glycoprotein. J Vet Diagn Invest 1999;11:20-26.
10. Guyre PM, Graziano RF, Goldstein J, et al. Increased potency of Fc-receptor-targeted antigens. Cancer Immunol Immunother 1997;45:146-148.
11. Hou YH, Chen J, Tong GZ, et al. A recombinant plasmid co-expressing swine ubiquitin and the GP5 encoding-gene of porcine reproductive and respiratory syndrome virus induces protective immunity in piglets. Vaccine 2008;26: 1438-1449.
12. Johnson CR, Griggs TF, Gnanandarajah J, and Murtaugh MP. Novel structural protein in porcine reproductive and respiratory syndrome virus encoded by an alternative ORF5 present in all arteriviruses. J Gen Virol 2011;92:1107-1116.
13. Kimman TG, Cornelissen LA, Moormann RJ, Rebel JM, and Stockhofe-Zurwieden N. Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology. Vaccine 2009;27:3704-3718.
14. Li B, Xiao S, Wang Y, et al. Immunogenicity of the highly pathogenic porcine reproductive and respiratory syndrome virus GP5 protein encoded by a synthetic ORF5 gene. Vaccine 2009;27:1957-1963.
15. Lopez OJ, Oliveira MF, Garcia EA, Kwon BJ, Doster A, and Osorio FA. Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent. Clin Vaccine Immunol 2007;14:269-275.
16. Lopez OJ, and Osorio FA. Role of neutralizing antibodies in PRRSV protective immunity. Vet Immunol Immunopathol 2004;102:155-163.
17. Loureiro S, Ren J, Phapugrangkul P, et al. Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines. J Virol 2011;85:3010-3014.
18. Meulenberg JJ. PRRSV, the virus. Vet Res 2000;31:11-21.
19. Meulenberg JJ, Petersen den Besten A, de Kluyver E, van Nieuwstadt A, Wensvoort G, and Moormann RJ. Molecular characterization of Lelystad virus. Vet Microbiol 1997;55: 197-202.
20. Murtaugh MP, Elam MR, and Kakach LT. Comparison of the structural protein coding sequences of the VR-2332 and Lelystad virus strains of the PRRS virus. Arch Virol 1995; 140:1451-1460.
21. Nelsen CJ, Murtaugh MP, and Faaberg KS. Porcine reproductive and respiratory syndrome virus comparison: divergent evolution on two continents. J Virol 1999;73:270-280.
22. Ostrowski M, Galeota JA, Jar AM, Platt KB, Osorio FA, and Lopez OJ. Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. J Virol 2002;76:4241-4250.
23. Pirzadeh B, and Dea S. Monoclonal antibodies to the ORF5 product of porcine reproductive and respiratory syndrome virus define linear neutralizing determinants. J Gen Virol 1997;78:1867-1873.
24. Plagemann PG, Rowland RR, and Faaberg KS. The primary neutralization epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is located in the middle of the GP5 ectodomain. Arch Virol 2002;147:2327-2347.
25. Plana Duran J, Climent I, Sarraseca J, et al. Baculovirus expression of proteins of porcine reproductive and respiratory syndrome virus strain Olot/91. Involvement of ORF3 and ORF5 proteins in protection. Virus Genes 1997;14:19-29.
26. Ren X, Wang M, Yin J, Ren Y, and Li G. Heterologous expression of fused genes encoding the glycoprotein 5 from PRRSV: a way for producing functional protein in prokaryotic microorganism. J Biotechnol 2010;147:130-135.
27. Robinson SR, Figueiredo MC, Abrahante JE, and Murtaugh MP. Immune response to ORF5a protein immunization is not protective against porcine reproductive and respiratory syndrome virus infection. Vet Microbiol 2013;164:281-285.
28. Roques E, Girard A, St-Louis MC, et al. Immunogenic and protective properties of GP5 and M structural proteins of porcine reproductive and respiratory syndrome virus expressed from replicating but nondisseminating adenovectors. Vet Res 2013;44:17.
29. Van Breedam W, Van Gorp H, Zhang JQ, Crocker PR, Delputte PL, and Nauwynck HJ. The M/GP(5) glycoprotein complex of porcine reproductive and respiratory syndrome virus binds the sialoadhesin receptor in a sialic acid-dependent manner. PLoS Pathogens 2010;6:e1000730.
30. Wang W, Chen X, Xue C, et al. Production and immunogenicity of chimeric virus-like particles containing porcine reproductive and respiratory syndrome virus GP5 protein. Vaccine 2012;30:7072-7077.
31. Weiland E, Wieczorek-Krohmer M, Kohl D, Conzelmann KK, and Weiland F. Monoclonal antibodies to the GP5 of porcine reproductive and respiratory syndrome virus are more effective in virus neutralization than monoclonal antibodies to the GP4. Vet Microbiol 1999;66:171-186.
32. Wensvoort G, de Kluyver EP, Pol JM, et al. Lelystad virus, the cause of porcine epidemic abortion and respiratory syndrome: a review of mystery swine disease research at Lelystad. Vet Microbiol 1992;33:185-193.
33. Wissink EH, van Wijk HA, Kroese MV, et al. The major envelope protein, GP5, of a European porcine reproductive and respiratory syndrome virus contains a neutralization epitope in its N-terminal ectodomain. J Gen Virol 2003;84: 1535-1543.
34. Xu XG, Wang ZS, Zhang Q, et al. Baculovirus as a PRRSV and PCV2 bivalent vaccine vector: baculovirus virions displaying simultaneously GP5 glycoprotein of PRRSV and capsid protein of PCV2. J Virol Methods 2012;179:359-366.
35. Yang Q, Li C, Wei Y, Huang W, and Wang LX. Expression, glycoform characterization, and antibody-binding of HIV-1 V3 glycopeptide domain fused with human IgG1-Fc. Bioconjugate Chem 2010;21:875-883.
36. Zhang MY, Wang Y, Mankowski MK, Ptak RG, and Dimitrov DS. Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: possible role of the prolonged half-life of the immunogen. Vaccine 2009;27:857-863.
37. Zhao H, Wang Y, Ma Z, Wang Y, and Feng WH. Recombinant Kluyveromyces lactis expressing highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) GP5 elicits mucosal and cell-mediated immune responses in mice. J Vet Sci 2014;15:199-208.
38. Zhao Y, Chapman DA, and Jones IM. Improving baculovirus recombination. Nucleic Acids Res 2003;31:E6-6.
39. Zheng Q, Chen D, Li P, et al. Co-expressing GP5 and M proteins under different promoters in recombinant modified vaccinia virus ankara (rMVA)-based vaccine vector enhanced the humoral and cellular immune responses of porcine reproductive and respiratory syndrome virus (PRRSV). Virus Genes 2007;35:585-595.